Lifevantage Corporation
$ 4.67
3.09%
25 Feb - close price
- Market Cap 59,745,000 USD
- Current Price $ 4.67
- High / Low $ 4.76 / 4.40
- Stock P/E 7.53
- Book Value 2.58
- EPS 0.62
- Next Earning Report -
- Dividend Per Share $0.18
- Dividend Yield 3.86 %
- Next Dividend Date 2026-03-16
- ROA 0.09 %
- ROE 0.25 %
- 52 Week High 17.40
- 52 Week Low 3.90
About
LifeVantage Corporation is dedicated to the identification, research, development and distribution of nutrigenomic activators, dietary supplements, nootropics, pre and probiotics, weight management, and skin and hair care products. The company is headquartered in Sandy, Utah.
Analyst Target Price
$8.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-03 | 2025-10-27 | 2025-09-04 | 2025-05-06 | 2025-02-05 | 2024-10-29 | 2024-08-28 | 2024-05-02 | 2024-01-30 | 2023-11-09 | 2023-08-28 | 2023-05-04 |
| Reported EPS | 0.15 | 0.18 | 0.17 | 0.26 | 0.22 | 0.15 | 0.14 | 0.21 | 0.1 | 0.13 | 0.17 | 0.08 |
| Estimated EPS | 0.1533 | 0.21 | 0.2 | 0.14 | 0.13 | 0.15 | 0.21 | 0.16 | 0.04 | 0.15 | 0.2 | 0.15 |
| Surprise | -0.0033 | -0.03 | -0.03 | 0.12 | 0.09 | 0 | -0.07 | 0.05 | 0.06 | -0.02 | -0.03 | -0.07 |
| Surprise Percentage | -2.1526% | -14.2857% | -15% | 85.7143% | 69.2308% | 0% | -33.3333% | 31.25% | 150% | -13.3333% | -15% | -46.6667% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-03-16 | 2025-12-15 | 2025-09-16 | 2025-06-13 | 2025-03-17 | 2024-12-16 | 2024-09-17 | 2024-06-14 | 2024-03-15 | 2023-12-15 |
| Amount | $0.045 | $0.045 | $0.045 | $0.045 | $0.04 | $0.04 | $0.04 | $0.04 | $0.035 | $0.035 |
Next Dividend Records
| Dividend per share (year): | $0.18 |
| Dividend Yield | 3.86% |
| Next Dividend Date | 2026-03-16 |
| Ex-Dividend Date | 2026-03-02 |
Recent News: LFVN
2026-02-23 07:36:29
LifeVantage, a direct selling company, has fully embraced the "biohacking" movement, which focuses on optimizing the body and mind through technology, tools, and science. The company leverages nutrigenomics with products like Protandim to support cellular function and combat aging. LifeVantage differentiates itself by integrating smart technologies, including AI and gamification, into its direct selling model to enhance distributor experience and global expansion.
2026-02-16 07:57:49
Short interest in Lifevantage Corporation (NASDAQ:LFVN) increased significantly by 32.2% to 3,664,089 shares as of January 30th, representing 36.7% of the stock shorted and a 13.1 days-to-cover ratio. This surge follows the company missing its quarterly earnings and revenue estimates, reporting $0.15 EPS against an expected $0.22 and $48.93 million in revenue compared to a $54.4 million consensus. Lifevantage also declared a quarterly dividend of $0.045, has a market capitalization of approximately $64.3 million, and holds a "Moderate Buy" consensus rating with a $5 price target.
2026-02-08 02:33:00
LifeVantage Corporation announced its Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock. The dividend will be paid on March 16, 2026, to stockholders of record as of the close of business on March 2, 2026. LifeVantage is a health and wellness company specializing in nutrigenomics, with products designed to activate optimal health processes at the cellular level.
2026-02-06 14:58:00
Lake Street Capital Markets has slashed its price target for Lifevantage Corporation (NASDAQ:LFVN) to $5.00 from $12.00, while maintaining a Buy rating. This adjustment follows the company's weaker-than-expected Q2 results and guidance, primarily due to increased competition in the weight loss market from pharmaceutical GLP-1s and an inventory obsolescence charge. Despite these challenges, the firm believes the current valuation reflects the headwinds, with potential upside from the LoveBiome acquisition and new products.
2026-02-06 14:28:31
LifeVantage Corporation (LFNV) has seen its share price drop 26% in the last month and 76% over the past year. Despite a low P/E ratio of 7.5x, suggesting potential undervaluation compared to other U.S. companies, analysts forecast a 26% annual earnings growth for the next three years, outpacing the broader market's 12% expectation. However, the market seems skeptical, leading to the stock trading at a P/E lower than what its growth prospects might suggest.
2026-02-06 14:28:31
LifeVantage Corporation (NASDAQ: LFVN) has announced a quarterly dividend of $0.045 per share, payable on March 16th to shareholders of record on March 2nd. The company recently reported earnings of $0.15 EPS, missing analysts' consensus of $0.22, and revenues of $48.93 million, below estimates of $54.40 million. LifeVantage has also set its FY 2026 guidance at $0.60-$0.80 EPS, and its shares are currently trading near their 52-week low.
